Nichd Neonatal Research Network
Clinical trials sponsored by Nichd Neonatal Research Network, explained in plain language.
-
Could timed light therapy save more premature babies?
Disease control OngoingThis study compares two ways of using phototherapy (light treatment) for jaundice in extremely premature infants (under 750 grams or 27 weeks gestation). One group gets continuous light, the other gets timed cycles based on bilirubin levels. The main goal is to see if cycled phot…
Phase: NA • Sponsor: NICHD Neonatal Research Network • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New study weighs risks of treating vs. watching heart defect in preemies
Disease control OngoingThis study looks at whether actively treating a heart condition called patent ductus arteriosus (PDA) in premature babies is better than simply monitoring it. About 482 infants born between 22 and 28 weeks of pregnancy will be followed to see which approach reduces the risk of de…
Phase: PHASE3 • Sponsor: NICHD Neonatal Research Network • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New combo therapy aims to save tiny lungs
Disease control OngoingThis Phase 3 trial tests whether adding budesonide (an anti-inflammatory) to standard surfactant treatment helps extremely preterm babies avoid chronic lung disease or death. About 642 infants born before 29 weeks or weighing under 1000 grams will receive either the combo or surf…
Phase: PHASE3 • Sponsor: NICHD Neonatal Research Network • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC